News stories about PhotoMedex (NASDAQ:PHMD) have trended somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PhotoMedex earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the medical equipment provider an impact score of 44.5435999895213 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of PhotoMedex (NASDAQ PHMD) traded up 0.0079% on Friday, hitting $1.2601. 59,173 shares of the stock traded hands. The company’s 50 day moving average is $1.14 and its 200 day moving average is $1.19. PhotoMedex has a one year low of $0.71 and a one year high of $5.60. The stock’s market cap is $7.76 million.

COPYRIGHT VIOLATION NOTICE: “PhotoMedex (PHMD) Receiving Somewhat Positive Press Coverage, Study Shows” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at

About PhotoMedex

PhotoMedex, Inc is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment.

Insider Buying and Selling by Quarter for PhotoMedex (NASDAQ:PHMD)

Receive News & Ratings for PhotoMedex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.